Literature DB >> 30591218

Upregulated circular RNA circ_0030235 predicts unfavorable prognosis in pancreatic ductal adenocarcinoma and facilitates cell progression by sponging miR-1253 and miR-1294.

Yi Xu1, Yue Yao2, Ping Gao3, Yunfu Cui4.   

Abstract

Accumulating evidence indicated that dysregulated circular RNAs (circRNAs) could play pivotal roles in cancer biology. A recent study demonstrated that circ_0030235 expression is upregulated in human pancreatic ductal adenocarcinoma (PDAC) by high-throughput circRNA microarray. In the current work, we aimed to elucidate the clinical significance, prognostic value, functional roles and mechanism of circ_0030235 in PDAC. Quantitative real time-PCR was used to detect circ_0030235 expression in PDAC tissue specimens and cell lines. The clinical significance of circ_0030235 was evaluated by Fisher's exact test, Kaplan-Meier curves, and Cox regression analysis. Cell growth, apoptosis, and metastatic properties were then explored after circ_0030235 knockdown/overexpression. Dual luciferase reporter assay was applied to detect the mechanisms of circ_0030235. As a result, the data documented that circ_0030235 was upregulated in PDAC cell lines and cancerous tissues compared with HPDE and matched normal tissue specimens, respectively. Overexpression of circ_0030235 in tumor samples is related to higher tumor stage and positive lymph node invasion. Additionally, analyses documented that high expression of circ_0030235 was associated with poor prognosis for PDAC patients. Knockdown of circ_0030235 by siRNAs inhibited cell growth, migratory and invasive potential, and promoted cell apoptosis. On the contrary, overexpression of circ_0030235 caused the opposite effect. Mechanistically, circ_0030235 directly sponges miR-1253 and miR-1294 in PDAC cells. What's more, the oncogenic properties of circ_0030235 was partly dependent on its suppression on miR-1253 and miR-1294. Overall, the results showed that circ_0030235 might act as an effective therapeutic target and indicate dismal prognosis for PDAC.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Circular RNA; Pancreatic ductal adenocarcinoma; circ_0030235; miR-1253; miR-1294

Mesh:

Substances:

Year:  2018        PMID: 30591218     DOI: 10.1016/j.bbrc.2018.12.088

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  35 in total

1.  Research progress on circularRNAs in pancreatic cancer: emerging but promising.

Authors:  Yi-Zhi Wang; Yang An; Bing-Qi Li; Jun Lu; Jun-Chao Guo
Journal:  Cancer Biol Ther       Date:  2019-05-28       Impact factor: 4.742

2.  Circular RNA circ_0084927 regulates proliferation, apoptosis, and invasion of breast cancer cells via miR-142-3p/ERC1 pathway.

Authors:  Guohua Gong; Jikai She; Danni Fu; Dong Zhen; Bin Zhang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  Biomarker potentials of miRNA-associated circRNAs in breast cancer (MCF-7) cells: an in vitro and in silico study.

Authors:  Sema Misir; Ceylan Hepokur; Yuksel Aliyazicioglu; Francisco J Enguita
Journal:  Mol Biol Rep       Date:  2021-03-28       Impact factor: 2.316

Review 4.  Biological functions, mechanisms, and clinical significance of circular RNA in pancreatic cancer: a promising rising star.

Authors:  Qun Chen; Jiajia Li; Peng Shen; Hao Yuan; Jie Yin; Wanli Ge; Wujun Wang; Guangbin Chen; Taoyue Yang; Bin Xiao; Yi Miao; Zipeng Lu; Pengfei Wu; Kuirong Jiang
Journal:  Cell Biosci       Date:  2022-06-21       Impact factor: 9.584

5.  Upregulated circRNA hsa_circ_0071036 promotes tumourigenesis of pancreatic cancer by sponging miR-489 and predicts unfavorable characteristics and prognosis.

Authors:  Xu Han; Yuan Fang; Pingping Chen; Yaolin Xu; Wentao Zhou; Yefei Rong; Jian-Ang Li; Wei Chen; Wenhui Lou
Journal:  Cell Cycle       Date:  2021-01-28       Impact factor: 4.534

6.  The decreased expression of hsa_circ_0043278 and its relationship with clinicopathological features of breast cancer.

Authors:  Chong Liu; Tao Han; Yue Shi
Journal:  Gland Surg       Date:  2020-12

7.  Impact Analysis of miR-1253 on Lung Cancer Progression Through Targeted Regulation of ANXA3.

Authors:  Qiang Liu; Shuai Wang; Guotian Pei; Yingshun Yang; Xianjun Min; Yuqing Huang; Jun Liu
Journal:  Cancer Manag Res       Date:  2021-02-19       Impact factor: 3.989

Review 8.  Recent Advances in the Potential Use of Circular RNA for the Diagnosis and Treatment of Pancreatic Cancer.

Authors:  Xinzhu Sun; Dongyan Liu; Nan Ge; Jintao Guo; Sheng Wang; Xiang Liu; Guoxin Wang; Siyu Sun
Journal:  Cancer Manag Res       Date:  2021-05-28       Impact factor: 3.989

Review 9.  Circular RNAs as novel potential biomarkers for pancreatic cancer.

Authors:  Shanshan Liu; Qiuyue Li; Yan Ma; Christopher Corpe; Jin Wang
Journal:  J Cancer       Date:  2021-06-01       Impact factor: 4.207

Review 10.  Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma.

Authors:  Geeta G Sharma; Yasuyuki Okada; Daniel Von Hoff; Ajay Goel
Journal:  Semin Cancer Biol       Date:  2020-10-10       Impact factor: 17.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.